JP2022500084A5 - - Google Patents
Info
- Publication number
- JP2022500084A5 JP2022500084A5 JP2021539336A JP2021539336A JP2022500084A5 JP 2022500084 A5 JP2022500084 A5 JP 2022500084A5 JP 2021539336 A JP2021539336 A JP 2021539336A JP 2021539336 A JP2021539336 A JP 2021539336A JP 2022500084 A5 JP2022500084 A5 JP 2022500084A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- acid sequence
- seq
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862730715P | 2018-09-13 | 2018-09-13 | |
| US62/730,715 | 2018-09-13 | ||
| PCT/US2019/050727 WO2020056077A1 (en) | 2018-09-13 | 2019-09-12 | Novel lilrb4 antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500084A JP2022500084A (ja) | 2022-01-04 |
| JP2022500084A5 true JP2022500084A5 (cg-RX-API-DMAC7.html) | 2022-07-19 |
| JP7534303B2 JP7534303B2 (ja) | 2024-08-14 |
Family
ID=69777846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539336A Active JP7534303B2 (ja) | 2018-09-13 | 2019-09-12 | 新規のlilrb4抗体およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12202895B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3849608B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7534303B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210061341A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112672760B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019339469A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3109366A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI851600B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020056077A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202100943B (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115551894A (zh) * | 2020-03-12 | 2022-12-30 | 以明生物免疫医疗公司 | 新型抗lilrb4抗体和衍生产物 |
| JP7754842B2 (ja) * | 2020-04-21 | 2025-10-15 | キアディス ファーマ インテレクチュアル プロパティ ビーブイ | フローサイトメトリー測定値を検証するための方法およびシステム |
| US20230400471A1 (en) * | 2020-10-15 | 2023-12-14 | Bioincept, Llc | Systems, compositions and methods of determining viability of embryos using the same |
| CN114563574B (zh) * | 2020-11-27 | 2025-03-04 | 中国科学院北京基因组研究所(国家生物信息中心) | 分子标记物组合及其用途 |
| JP2022147203A (ja) * | 2021-03-23 | 2022-10-06 | 国立大学法人東北大学 | 抗ヒト免疫抑制性受容体lilrb4モノクローナル抗体又はその抗体断片、免疫チェックポイント阻害剤、免疫チェックポイント関連疾患の治療剤及びヒト免疫抑制性受容体lilrb4の測定方法 |
| CA3225360A1 (en) | 2021-07-12 | 2023-01-19 | Victoria COTHAM | Online native mass spectrometry methods for assaying viral particles |
| AU2022318734A1 (en) * | 2021-07-28 | 2024-02-08 | Merck Sharp & Dohme Llc | Methods for treating acute myeloid leukemia with anti-ilt3 antibodies |
| EP4499683A1 (en) | 2022-03-29 | 2025-02-05 | NGM Biopharmaceuticals, Inc. | Ilt3 and cd3 binding agents and methods of use thereof |
| KR20250025354A (ko) | 2022-04-25 | 2025-02-21 | 비온드 바이오로직스 엘티디 | 항-ilt3 항체 및 이의 용도 |
| WO2023235699A1 (en) * | 2022-05-31 | 2023-12-07 | Jounce Therapeutics, Inc. | Antibodies to lilrb4 and uses thereof |
| CN119343376A (zh) * | 2022-06-06 | 2025-01-21 | 德琪(杭州)生物有限公司 | 新颖的抗lilrb4抗体及其用途 |
| CN114716554B (zh) * | 2022-06-08 | 2022-08-26 | 尚健单抗(北京)生物技术有限公司 | 抗原结合蛋白及其应用 |
| CN115925941B (zh) * | 2022-06-08 | 2026-04-03 | 北京科诺信诚科技有限公司 | 靶向人lilrb4的纳米抗体及其应用 |
| CN117362433A (zh) * | 2022-06-30 | 2024-01-09 | 杭州尚健生物技术有限公司 | 分离的抗原结合蛋白及其用途 |
| EP4561623A4 (en) * | 2022-07-28 | 2026-07-22 | Merck Sharp & Dohme Llc | TREATMENT METHODS FOR CHRONIC MYELOMONOCYTIC LEUKEMIA WITH ANTI-ILT3 ANTIBODIES |
| WO2024140710A1 (zh) * | 2022-12-26 | 2024-07-04 | 华夏英泰(北京)生物技术有限公司 | 一种特异性结合lilrb4的合成t细胞受体抗原受体及其应用 |
| CN115873119B (zh) * | 2022-12-30 | 2026-01-23 | 北京东方百泰生物科技股份有限公司 | 一种抗lilrb4单克隆抗体的纯化方法 |
| JP2026504928A (ja) * | 2023-01-20 | 2026-02-10 | ワシントン・ユニバーシティ | Lilrb4/ilt3アンタゴニスト組成物およびその使用方法 |
| CN119894934A (zh) | 2023-05-18 | 2025-04-25 | 南京维立志博生物科技股份有限公司 | 结合lilrb4和cd3的抗体及其用途 |
| CN122444874A (zh) * | 2023-05-20 | 2026-07-24 | 四川大学 | 一种抗lilrb4/lilrb3抗体及其用途 |
| EP4780848A1 (en) | 2023-09-20 | 2026-07-29 | Biond Biologics Ltd. | Anti-ilt3 blockade combinations |
| WO2025119253A1 (en) * | 2023-12-06 | 2025-06-12 | Antengene (Hangzhou) Biologics Co., Ltd. | Novel antibodies that bind to cd3 and lilrb4, and uses thereof |
| TW202543679A (zh) * | 2023-12-29 | 2025-11-16 | 大陸商杭州尚健生物技術有限公司 | 一種免疫綴合物及其用途 |
| WO2025141589A1 (en) | 2023-12-31 | 2025-07-03 | Biond Biologics Ltd. | Treatment of cancer with anti-ilt3 antibodies |
| WO2025188047A1 (en) * | 2024-03-04 | 2025-09-12 | Abl Bio, Inc. | Anti-lilrb4 antibodies and anti-lilrb4/anti-4-1bb bispecific antibodies and uses thereof |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
| US4867973A (en) | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| US4472509A (en) | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4938948A (en) | 1985-10-07 | 1990-07-03 | Cetus Corporation | Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies |
| US4680338A (en) | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・2・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
| US5563250A (en) | 1987-12-02 | 1996-10-08 | Neorx Corporation | Cleavable conjugates for the delivery and release of agents in native form |
| US5141648A (en) | 1987-12-02 | 1992-08-25 | Neorx Corporation | Methods for isolating compounds using cleavable linker bound matrices |
| JPH049249A (ja) | 1990-04-27 | 1992-01-14 | Kusuda:Kk | 塗型剤吹き付け機 |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
| WO1994012520A1 (en) | 1992-11-20 | 1994-06-09 | Enzon, Inc. | Linker for linked fusion polypeptides |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| WO1996040662A2 (en) | 1995-06-07 | 1996-12-19 | Cellpro, Incorporated | Aminooxy-containing linker compounds and their application in conjugates |
| US6277375B1 (en) | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| JP4334141B2 (ja) | 1998-04-20 | 2009-09-30 | グリカート バイオテクノロジー アクチェンゲゼルシャフト | 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作 |
| PT1137789E (pt) | 1998-12-09 | 2010-10-21 | Phyton Holdings Llc | Um método para produzir glicoproteínas possuindo glicosilação de tipo humano |
| HUP0104865A3 (en) | 1999-01-15 | 2004-07-28 | Genentech Inc | Polypeptide variants with altered effector function |
| EP2275540B1 (en) | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| US7029872B2 (en) | 2000-06-28 | 2006-04-18 | Glycofi, Inc | Methods for producing modified glycoproteins |
| US7449308B2 (en) | 2000-06-28 | 2008-11-11 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
| US7632983B2 (en) | 2000-07-31 | 2009-12-15 | Biolex Therapeutics, Inc. | Expression of monoclonal antibodies in duckweed |
| PL213948B1 (pl) | 2001-10-25 | 2013-05-31 | Genentech Inc | Kompozycje zawierajace glikoproteine, czasteczka kwasu nukleinowego kodujaca te glikoproteine, komórka gospodarza, sposób wytwarzania glikoproteiny, kompozycja do zastosowania do leczenia, zastosowanie kompozycji i zestaw zawierajacy kompozycje |
| KR20050000380A (ko) | 2002-04-09 | 2005-01-03 | 교와 핫꼬 고교 가부시끼가이샤 | 게놈이 개변된 세포 |
| US20070134247A9 (en) | 2002-04-12 | 2007-06-14 | Ramot At Tel Aviv University Ltd. | Prevention of brain inflammation as a result of induced autoimmune response |
| US7410483B2 (en) | 2003-05-23 | 2008-08-12 | Novare Surgical Systems, Inc. | Hand-actuated device for remote manipulation of a grasping tool |
| WO2005120571A2 (en) | 2004-06-07 | 2005-12-22 | Ramot At Tel Aviv University Ltd. | Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation |
| CA2598454C (en) | 2005-02-18 | 2013-04-09 | Medarex, Inc. | Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| WO2008094176A2 (en) * | 2006-06-19 | 2008-08-07 | Tolerx, Inc. | Ilt3 binding molecules and uses therefor |
| KR20090130029A (ko) | 2007-03-07 | 2009-12-17 | 글리코파이, 인크. | 푸코실화가 변형된 당단백질의 제조 |
| KR20180005753A (ko) * | 2008-06-25 | 2018-01-16 | 에스바테크 - 어 노바티스 컴파니 엘엘씨 | Vegf를 억제하는 안정하고 가용성인 항체 |
| US9696312B2 (en) * | 2011-09-02 | 2017-07-04 | The Trustees Of Columbia University In The City Of New York | Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand |
| US20150174203A1 (en) | 2012-05-30 | 2015-06-25 | Icahn School Of Medicine At Mount Sinai | Compositions And Methods For Modulating Pro-Inflammatory Immune Response |
| CA3218106A1 (en) | 2015-03-06 | 2016-09-15 | The Board Of Regents Of The University Of Texas System | Anti-lilrb antibodies and their use in detecting and treating cancer |
| CN108026172B (zh) * | 2015-06-26 | 2022-04-29 | 赛诺菲生物技术公司 | 单克隆抗il-1racp抗体 |
| EP3448874A4 (en) * | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| WO2018022881A2 (en) | 2016-07-29 | 2018-02-01 | The Board Of Regents Of The University Of Texas System | Methods for identifying lilrb-blocking antibodies |
| EP3538141A4 (en) | 2016-11-10 | 2020-07-15 | Merck Sharp & Dohme Corp. | LIGAND ILT3 |
| MA47468A (fr) | 2017-02-09 | 2019-12-18 | Bluefin Biomedicine Inc | Anticorps anti-ilt3 et conjugués anticorps-médicament |
| WO2019094360A1 (en) | 2017-11-07 | 2019-05-16 | The Board Of Regents Of The University Of Texas System | Targeting lilrb4 with car-t or car-nk cells in the treatment of cancer |
-
2019
- 2019-09-12 AU AU2019339469A patent/AU2019339469A1/en not_active Abandoned
- 2019-09-12 EP EP19860440.7A patent/EP3849608B1/en active Active
- 2019-09-12 JP JP2021539336A patent/JP7534303B2/ja active Active
- 2019-09-12 CN CN201980059865.6A patent/CN112672760B/zh active Active
- 2019-09-12 WO PCT/US2019/050727 patent/WO2020056077A1/en not_active Ceased
- 2019-09-12 CA CA3109366A patent/CA3109366A1/en active Pending
- 2019-09-12 TW TW108133096A patent/TWI851600B/zh active
- 2019-09-12 US US17/275,838 patent/US12202895B2/en active Active
- 2019-09-12 KR KR1020217007352A patent/KR20210061341A/ko not_active Ceased
-
2021
- 2021-02-11 ZA ZA2021/00943A patent/ZA202100943B/en unknown
-
2025
- 2025-01-21 US US19/032,893 patent/US20250250336A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260027225A1 (en) | Monoclonal antibodies specific for fibroblast growth factor receptor 4 (fgfr4) and methods of their use | |
| CN112111008B (zh) | 抗cd73抗体及其应用 | |
| US9316646B2 (en) | Anti-human ROR1 antibodies | |
| JP2023513158A5 (cg-RX-API-DMAC7.html) | ||
| CN114634569B (zh) | 高亲和力b7-h6抗体和抗体片段 | |
| JP6577016B2 (ja) | 治療及び診断のための抗コラーゲン抗体 | |
| JP2023508277A5 (cg-RX-API-DMAC7.html) | ||
| AU2008299593B2 (en) | Novel P2X7 epitopes | |
| HK1258375A1 (zh) | 人源化抗-cll-1抗体 | |
| AU2026203373A1 (en) | High affinity monoclonal antibodies targeting glypican-1 and methods of use | |
| CN110382533B (zh) | 特异性结合CD66c的抗体及其用途 | |
| JP2023546791A (ja) | がん治療のための代替的にフォーマット化された抗メソテリン抗体の組成物及び使用 | |
| Cheung et al. | Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B | |
| CN115916349B (zh) | 针对Lewis Y的人源化抗体 | |
| AU2015252014B2 (en) | Anti-human ror1 antibodies | |
| US12516096B2 (en) | Composition and use of humoral immune suppressor antagonists for the treatment of humoral immune suppressed diseases | |
| WO2026035616A1 (en) | Combinations for the treatment of cancer | |
| WO2024105180A1 (en) | Predictive efficacy biomarkers for anti-sirpa antibodies | |
| WO2023138620A1 (zh) | 抗pdl1/igf1r双特异性抗体、其制备方法及用途 | |
| WO2007022424A2 (en) | Laminin receptor targeting method for delivering a toxic agent inside a cell | |
| JP2026506269A (ja) | 組換え抗体及びその用途 | |
| CN121930366A (zh) | 一种靶向T细胞、Her2阳性细胞的双特异性抗体并串联4-1BBL的融合蛋白及其应用 | |
| CN119855617A (zh) | 人源化抗pvr抗体的药物偶联物 | |
| HK40033064A (en) | Anti-folate receptor 1 antibodies and uses thereof | |
| HK40031476A (en) | Anti-claudin 18.2 antibodies and uses thereof |